IRIS
SILVESTRO, MARCELLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.076
AS - Asia 1.536
NA - Nord America 1.204
SA - Sud America 200
Continente sconosciuto - Info sul continente non disponibili 101
AF - Africa 17
OC - Oceania 7
Totale 7.141
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.255
US - Stati Uniti d'America 1.155
SG - Singapore 592
CN - Cina 311
IT - Italia 296
VN - Vietnam 252
IE - Irlanda 206
HK - Hong Kong 175
BR - Brasile 164
DE - Germania 90
GB - Regno Unito 62
KR - Corea 56
JP - Giappone 50
IN - India 35
CA - Canada 31
FI - Finlandia 27
SE - Svezia 19
AT - Austria 18
GR - Grecia 16
AR - Argentina 14
CZ - Repubblica Ceca 14
UA - Ucraina 12
ES - Italia 11
BE - Belgio 10
MX - Messico 10
NL - Olanda 10
BD - Bangladesh 9
FR - Francia 8
AU - Australia 6
CH - Svizzera 6
PK - Pakistan 6
TR - Turchia 6
CO - Colombia 5
DZ - Algeria 5
IQ - Iraq 5
PL - Polonia 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
EG - Egitto 4
ID - Indonesia 4
IR - Iran 4
PY - Paraguay 4
UZ - Uzbekistan 4
MY - Malesia 3
PE - Perù 3
PH - Filippine 3
PT - Portogallo 3
ZA - Sudafrica 3
CL - Cile 2
CR - Costa Rica 2
KE - Kenya 2
LV - Lettonia 2
MA - Marocco 2
MT - Malta 2
NP - Nepal 2
SA - Arabia Saudita 2
TW - Taiwan 2
UY - Uruguay 2
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
CY - Cipro 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
NI - Nicaragua 1
NR - Nauru 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RO - Romania 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.041
Salva come PNG Salva come JPEG
Città #
Moscow 1.235
Singapore 301
San Jose 270
Dublin 206
Hong Kong 172
Santa Clara 151
Ashburn 107
Naples 79
Ho Chi Minh City 77
Hanoi 68
Beijing 59
Chandler 56
Seoul 56
Hefei 41
Munich 38
Los Angeles 36
Dallas 26
Jacksonville 26
Roxbury 26
New York 25
Princeton 25
Bremen 24
Da Nang 20
Bengaluru 19
The Dalles 19
Medford 18
Helsinki 14
São Paulo 14
Aversa 13
Brno 13
Des Moines 11
Haiphong 10
Turku 10
Vienna 10
Bến Tre 9
Caserta 9
Milan 9
Montreal 9
Orem 9
Reggio Emilia 9
Cambridge 8
Viterbo 8
Belo Horizonte 7
Boardman 7
Hasselt 7
London 7
Nanjing 7
Napoli 7
Nuremberg 7
Stockholm 7
Atlanta 6
Council Bluffs 6
Frankfurt am Main 6
Hillsboro 6
Phoenix 6
San Francisco 6
Tokyo 6
Amsterdam 5
Biên Hòa 5
Bologna 5
Brooklyn 5
Chennai 5
Falkenstein 5
Guarulhos 5
Hebei 5
Mexico City 5
Norwalk 5
Toronto 5
Wilmington 5
Avella 4
Boston 4
Bắc Ninh 4
Curitiba 4
Dhaka 4
Guangzhou 4
Hangzhou 4
Hải Dương 4
Ninh Bình 4
Sacramento 4
Salerno 4
Shenyang 4
Tashkent 4
Warsaw 4
Ann Arbor 3
Bari 3
Brussels 3
Buffalo 3
Can Tho 3
Chicago 3
Denver 3
Florence 3
Houston 3
Memphis 3
Perugia 3
Phủ Lý 3
Porto Alegre 3
Rio de Janeiro 3
Rudolfstetten 3
Seattle 3
São Leopoldo 3
Totale 3.610
Salva come PNG Salva come JPEG
Nome #
A subjective cognitive impairments scale for migraine attacks: validation of the Italian version of the MIG-SCOG 178
Resting state fMRI analysis of pseudobulbar affect in Amyotrophic Lateral Sclerosis (ALS): motor dysfunction of emotional expression 175
Telemedicine application to headache: a critical review 170
Cluster headache pathophysiology: What we have learned from advanced neuroimaging 169
Can Craniometry Play a Role in Cluster Headache Diagnosis? A Pilot Exploratory TC-3D Based Study 159
Cognitive, behavioral, and brain functional connectivity correlates of fatigue in amyotrophic lateral sclerosis 157
Cognitive and morphometric features of mild cognitive impairment reversion in early patients with Parkinson's disease 155
Advanced visual network and cerebellar hyperresponsiveness to trigeminal nociception in migraine with aura 155
Cognitive Networks Disarrangement in Patients With Migraine Predicts Cutaneous Allodynia 150
Infodemiology of cluster headache seasonality: A proof of concept by a Google Trends analysis 147
Resting-state network connectivity changes in drug-naive Parkinson's disease patients with probable REM sleep behavior disorder 147
Arterial spin labeling MRI applied to migraine: current insights and future perspectives 142
Advances in migraine neuroimaging and clinical utility: from the MRI to the bedside 140
Brain neurovascular coupling in amyotrophic lateral sclerosis: Correlations with disease progression and cognitive impairment 133
Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail 130
Effectiveness and safety of CGRP monoclonal antibodies in migraine related to mitochondrial diseases in patients with NARP and PEO syndromes 128
Effectiveness and Safety of CGRP-mAbs in Menstrual-Related Migraine: A Real-World Experience 127
Coping Strategies in Migraine without Aura: A Cross-Sectional Study 123
Disconnectome of the migraine brain: a "connectopathy" model 121
Emerging drugs for the preventive treatment of migraine: a review of CGRP monoclonal antibodies and gepants trials 114
Readability Analysis of Online Headache and Migraine Information 113
Galcanezumab effect on "whole pain burden" and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience 113
Reduced neurovascular coupling of the visual network in migraine patients with aura as revealed with arterial spin labeling MRI: is there a demand-supply mismatch behind the scenes? 111
The "Cluster-SUNCT Syndrome": The Lumper-Splitter Problem 111
Resting-State Functional MRI Approaches to Parkinsonisms and Related Dementia 110
Psychological Support for Family Caregivers of Patients With Amyotrophic Lateral Sclerosis at the Time of the Coronavirus Disease 2019 Pandemic: A Pilot Study Using a Telemedicine Approach 109
Screening of visuospatial abilities in amyotrophic lateral sclerosis (ALS): a pilot study using the battery for visuospatial abilities (BVA) 108
The conundrum of relationship between pain and visual pathway in migraine with aura 105
Validation of new diagnostic criteria for fatigue in patients with Parkinson disease 103
Intrinsic brain functional connectivity predicts treatment-related motor complications in early Parkinson’s disease patients 103
Dihydroergotamine mesylate nasal spray: an acute treatment option for migraine in adults 102
Headache Worsening after COVID-19 Vaccination: An Online Questionnaire-Based Study on 841 Patients with Migraine 99
SUNCT-Induced Jaw Opening: A Rare Trigeminal Autonomic Phenotype 98
The "Ram's Horns Sign": A Case Report of an Unusual Side Effect of OnabotulinumtoxinA in a Chronic Migraine Patient 95
Perceived ease-of-usability and local tolerability using CGRP monoclonal antibody autoinjectors vs. syringes: an online questionnaire-based study in patients with migraine 94
Erenumab Efficacy on Comorbid Cluster Headache in Patients With Migraine: A Real-World Case Series 93
Migraine as a Cortical Brain Disorder 93
A case of rapidly progressive juvenile amyotrophic lateral sclerosis associated with a pathogenetic heterozygous de novo variant in the FUS gene 92
Migraine in the Time of COVID-19 91
Functional neuroimaging biomarkers in migraine: diagnostic, prognostic and therapeutic implications 89
Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience 88
Recent Insights in Migraine With Aura: A Narrative Review of Advanced Neuroimaging 87
Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients 85
"Forced Normalization": Could It Occur Also in Migraine Patients? 83
Functional connectivity changes in complex migraine aura: beyond the visual network 78
Shedding light on migraine with aura: the clarifying role of advanced neuroimaging investigations 76
No additional benefit with detoxification strategies: A real world experience in 200 patients with chronic migraine and either simple or complex MOH treated with CGRP monoclonal antibodies 75
Additive Interaction Between Onabotulinumtoxin-A and Erenumab in Patients With Refractory Migraine 74
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study 74
Pain Perception and Migraine 73
A 67-Year-Old Woman With Recurrent Headache, Migratory Focal Symptoms, and Impaired Consciousness 70
Evidence-based guidelines for the pharmacological treatment of migraine 69
Migraine Treatment: Towards New Pharmacological Targets 69
Evidence-based guidelines for the pharmacological treatment of migraine, summary version 69
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study 68
Excellent Response to OnabotulinumtoxinA: Different Definitions, Different Predictors 67
Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study) 63
The relevance of cortical thickness in migraine sufferers and implications to therapy 62
Monoclonal antibodies targeting the calcitonin gene-related peptide pathway improve the effectiveness of acute medication—a real-world study 60
Refractory migraine profile in CGRP-monoclonal antibodies scenario 58
Functional Changes of the Perigenual Part of the Anterior Cingulate Cortex after External Trigeminal Neurostimulation in Migraine Patients 57
Safety of Onabotulinumtoxin-A for Chronic Migraine During Pregnancy and Breastfeeding: A Narrative Review 57
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN) 55
Effectiveness and tolerability of atogepant as preventive treatment in resistant individuals with chronic migraine: Six-month real-world evidence 54
Migraine Does Not Affect Pain Intensity Perception: A Cross-Sectional Study 53
Sex differences in the clinical features of 2,841 patients with migraine: a post-hoc, multicenter, cross-sectional study 53
Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men 50
OnabotulinumtoxinA in elderly patients with chronic migraine: insights from a real-life European multicenter study 50
Prospective memory is dysfunctional in migraine without aura 49
Pain-Related Brain Connectivity Changes in Migraine: A Narrative Review and Proof of Concept about Possible Novel Treatments Interference 49
Exploring the multifaceted characteristics of aura in migraine: A multicenter, cross-sectional study 44
Idiopathic hypertrophic pachymeningitis mimicking hemicrania continua: An unusual clinical case 41
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study 41
Physiopathology of Migraine: What Have We Learned from Functional Imaging? 38
Sustained Efficacy, Safety and High Adherence Rate of Onabotulinum Toxin Type A in Chronic Migraine Patients: A Multicentric Prospective Real-Life Study 37
From mild cognitive impairment to normal cognition in Parkinson's disease: The role of brain network architecture 9
Subcortical microstructural impairment in amyotrophic lateral sclerosis: clinical correlates of neurite orientation dispersion and density imaging (NODDI) changes 4
Totale 7.141
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.190
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.190
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022199 0 5 9 12 65 8 3 5 6 9 22 55
2022/2023339 40 12 6 18 43 13 0 15 174 2 13 3
2023/2024237 11 19 11 13 60 28 10 10 6 4 16 49
2024/2025817 1 20 12 21 154 76 104 63 140 83 91 52
2025/20265.290 167 211 182 174 534 2.983 311 224 242 136 84 42
2026/202790 36 54 0 0 0 0 0 0 0 0 0 0
Totale 7.141